日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BRAT1 - a new therapeutic target for glioblastoma

BRAT1——胶质母细胞瘤的新治疗靶点

Alicia Haydo, Jennifer Schmidt, Alisha Crider, Tim Kögler, Johanna Ertl, Stephanie Hehlgans, Marina E Hoffmann, Rajeshwari Rathore, Ömer Güllülü, Yecheng Wang, Xiangke Zhang, Christel Herold-Mende, Francesco Pampaloni, Irmgard Tegeder, Ivan Dikic, Mingji Dai, Franz Rödel, Donat Kögel, Benedikt Linde

Tolerability and Adverse Effects in a Specialized Heart Failure Guideline-Directed Medical Therapy Optimization Program

在专门的心力衰竭指南指导的药物治疗优化方案中,耐受性和不良反应

Velasco, Claudia Mae; Baksh, Gladys; Haydo, Michele; Reesor, Heather; Boehmer, John; Ali, Omaima

Development of a Potent and Selective G2A (GPR132) Agonist.

开发一种高效选择性的G2A(GPR132)激动剂

Hernandez-Olmos Victor, Heering Jan, Marinescu Beatrice, Schermeng Tina, Ivanov Vladimir V, Moroz Yurii S, Nevermann Sheila, Mathes Marius, Ehrler Johanna H M, Alnouri Mohamad Wessam, Wolf Markus, Haydo Alicia S, Schmachtel Tessa, Zaliani Andrea, Höfner Georg, Kaiser Astrid, Schubert-Zsilavecz Manfred, Beck-Sickinger Annette G, Offermanns Stefan, Gribbon Philipp, Rieger Michael A, Merk Daniel, Sisignano Marco, Steinhilber Dieter, Proschak Ewgenij

Combining organotypic tissue culture with light-sheet microscopy (OTCxLSFM) to study glioma invasion

将器官型组织培养与光片显微镜 (OTCxLSFM) 相结合来研究胶质瘤侵袭

Alicia Haydo, Andrej Wehle, Christel Herold-Mende, Donat Kögel, Francesco Pampaloni, Benedikt Linder

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study

局部晚期直肠癌综合治疗期间的连续循环肿瘤 DNA 分析:一项前瞻性生物标志物研究

Jeanne Tie #, Joshua D Cohen #, Yuxuan Wang, Lu Li, Michael Christie, Koen Simons, Hany Elsaleh, Suzanne Kosmider, Rachel Wong, Desmond Yip, Margaret Lee, Ben Tran, David Rangiah, Matthew Burge, David Goldstein, Madhu Singh, Iain Skinner, Ian Faragher, Matthew Croxford, Carolyn Bampton, Andrew Haydo